MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
MIRA Pharmaceuticals Inc MIRA
$1.07
▼ -0.93%
($-0.01)
Open
$1.08
Prev Close
$1.08
Day Range
$1.06 – $1.10
52W Range
$0.90 – $2.45
Market Cap
$44.54M
Beta
1.60
EPS (TTM)
$-0.32
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-08-03 |
| Shares Out. | 42,020,000 |
| Website | mirapharmaceuticals.com/ ↗ |
| Phone | 18133695150 |
MIRA Pharmaceuticals Inc is a publicly traded company under the ticker symbol MIRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-05-01)